Literature DB >> 31496166

[Advances in serum biomarkers for early diagnosis of gastric cancer].

Yunzhu Zhang1, Chunpeng Zhu1, Xinliang Lu1.   

Abstract

Early diagnosis is the key to improve the prognosis of gastric cancer. How to screen out high-risk subjects of gastric cancer in population is a hot spot. Serum-based early detection of gastric cancer is suitable for high-risk population screening, which is more convenient and safer. This article reviews the diagnostic value of serum biomarkers for gastric cancer, including serum DNA methylation, various RNAs, pepsinogen, gastrin, osteopontin, MG7-Ag and CA724. Until now, there is still lack of ideal biomarkers for gastric cancer, and searching for specific RNAs may be promising for early diagnosis and screening of gastric cancer.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31496166      PMCID： PMC8800736          DOI： 10.3785/j.issn.1008-9292.2019.06.14

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN： 1008-9292


  51 in total

1.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations.

Authors:  F Kitahara; K Kobayashi; T Sato; Y Kojima; T Araki; M A Fujino
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

2.  A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population.

Authors:  Liping Sun; Huakang Tu; Jingwei Liu; Yuehua Gong; Qian Xu; Jingjing Jing; Nannan Dong; Yuan Yuan
Journal:  Scand J Gastroenterol       Date:  2014-08-26       Impact factor: 2.423

3.  Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.

Authors:  Feng Yang; Xuchao Xue; Luming Zheng; Jianwei Bi; Yuhong Zhou; Kangkang Zhi; Yan Gu; Guoen Fang
Journal:  FEBS J       Date:  2014-01-15       Impact factor: 5.542

Review 4.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

5.  Reprimo as a potential biomarker for early detection in gastric cancer.

Authors:  Carolina Bernal; Francisco Aguayo; Cynthia Villarroel; Macarena Vargas; Ignacio Díaz; Francisco J Ossandon; Eudocia Santibáñez; Mariana Palma; Edmundo Aravena; Carlos Barrientos; Alejandro H Corvalan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 6.  Gastric cancer pathology and underlying molecular mechanisms.

Authors:  Heike I Grabsch; Patrick Tan
Journal:  Dig Surg       Date:  2013-07-18       Impact factor: 2.588

7.  Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer.

Authors:  Jianhong Wu; Guangxin Li; Zeyou Wang; Yongliang Yao; Rui Chen; XiongYong Pu; Jianjun Wang
Journal:  Dis Markers       Date:  2015-05-03       Impact factor: 3.434

8.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

9.  Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.

Authors:  Fumie Ikeda; Kentaro Shikata; Jun Hata; Masayo Fukuhara; Yoichiro Hirakawa; Tomoyuki Ohara; Naoko Mukai; Masaharu Nagata; Daigo Yoshida; Koji Yonemoto; Motohiro Esaki; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  J Epidemiol       Date:  2016-06-04       Impact factor: 3.211

10.  The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research.

Authors:  Yuling Tong; Yulian Wu; Zhenya Song; Yingying Yu; Xinyan Yu
Journal:  BMC Gastroenterol       Date:  2017-07-20       Impact factor: 3.067
View more
  4 in total

1.  Prognosis of patients with early gastric carcinoma treated by endoscopic submucosal dissection and risk factors for additional postoperative surgery.

Authors:  Shuang Jiang; Dahe Ge; Kaijun Shou
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer.

Authors:  Yuejiao Zhong; Qingyu Fan; Zhaofei Zhou; Yajing Wang; Kang He; Jianwei Lu
Journal:  Cancer Manag Res       Date:  2020-05-05       Impact factor: 3.989

3.  Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines.

Authors:  Jishu Gu; Xuejiao Ni; Jinfeng Ji; Guohua Wei; Lei Shi; Chunming Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-27       Impact factor: 2.650

4.  Knockdown of Gastrin Promotes Apoptosis of Gastric Cancer Cells by Decreasing ROS Generation.

Authors:  Yan Liu; Jihai Zhu; Jun Liu; Xueman Ma; Jun Zhao; Zhanhai Su
Journal:  Biomed Res Int       Date:  2021-04-14       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.